Discover how NTRX-07, a first-in-class small molecule targeting microglial activity, offers a novel immunology-based strategy for Alzheimer’s disease by reducing neuroinflammation, enhancing amyloid-β clearance, and promoting neuroprotective repair pathways.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs